Safety and immunogenicity profile of human papillomavirus-16/18 AS04 adjuvant cervical cancer vaccine: a randomized controlled trial in healthy adolescent girls of Bangladesh. [electronic resource]
Producer: 20120206Description: 36-41 p. digitalISSN:- 1465-3621
- Adjuvants, Immunologic
- Adolescent
- Antibodies, Viral -- biosynthesis
- Bangladesh -- epidemiology
- Child
- Female
- Human papillomavirus 16 -- immunology
- Human papillomavirus 18 -- immunology
- Humans
- Papillomavirus Infections -- prevention & control
- Papillomavirus Vaccines -- adverse effects
- Uterine Cervical Neoplasms -- epidemiology
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.